BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Harissi-dagher M, Khan BF, Schaumberg DA, Dohlman CH. Importance of Nutrition to Corneal Grafts When Used as a Carrier of the Boston Keratoprosthesis. Cornea 2007;26:564-8. [DOI: 10.1097/ico.0b013e318041f0a6] [Cited by in Crossref: 81] [Cited by in F6Publishing: 16] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Ament JD, Spurr-Michaud SJ, Dohlman CH, Gipson IK. The Boston Keratoprosthesis: comparing corneal epithelial cell compatibility with titanium and PMMA. Cornea 2009;28:808-11. [PMID: 19574903 DOI: 10.1097/ICO.0b013e31819670ac] [Cited by in Crossref: 30] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
2 Abdelaziz M, Dohlman CH, Sayegh RR. Measuring Forward Light Scatter by the Boston Keratoprosthesis in Various Configurations. Cornea 2017;36:732-5. [PMID: 28476052 DOI: 10.1097/ICO.0000000000001197] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
3 Konstantopoulos A, Tan XW, Goh GT, Saraswathi P, Chen L, Nyein CL, Zhou L, Beuerman R, Tan DT, Mehta JS. Prophylactic Vancomycin Drops Reduce the Severity of Early Bacterial Keratitis in Keratoprosthesis. PLoS One 2015;10:e0139653. [PMID: 26460791 DOI: 10.1371/journal.pone.0139653] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
4 Robert MC, Arafat SN, Ciolino JB. Collagen cross-linking of the Boston keratoprosthesis donor carrier to prevent corneal melting in high-risk patients. Eye Contact Lens 2014;40:376-81. [PMID: 25320957 DOI: 10.1097/ICL.0000000000000081] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
5 Moshirfar M, Moody JJ, Barke MR, Martheswaran T, Thomson AC, Thomson RJ, Somani SN, Shmunes KM, Ronquillo YC, Hoopes P. The Historical Development and an Overview of Contemporary Keratoprostheses. Survey of Ophthalmology 2022. [DOI: 10.1016/j.survophthal.2022.01.005] [Reference Citation Analysis]
6 Dong Y, Qiu Z, Liu X, Wang L, Yang J, Huang Y, Cui F. Biomechanical evaluation of different hydroxyapatite coatings on titanium for keratoprosthesis. Front Mater Sci 2015;9:303-10. [DOI: 10.1007/s11706-015-0305-9] [Reference Citation Analysis]
7 Scotto R, Vagge A, Traverso CE. Corneal graft dellen in a patient implanted with a Boston keratoprosthesis type 1. Int Ophthalmol 2017;37:263-6. [PMID: 27068827 DOI: 10.1007/s10792-016-0227-2] [Reference Citation Analysis]
8 Harissi-Dagher M, Slim E. [Boston keratoprosthesis type 1]. J Fr Ophtalmol 2019;42:295-302. [PMID: 30857801 DOI: 10.1016/j.jfo.2018.08.010] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Arafat SN, Robert MC, Shukla AN, Dohlman CH, Chodosh J, Ciolino JB. UV cross-linking of donor corneas confers resistance to keratolysis. Cornea 2014;33:955-9. [PMID: 25014151 DOI: 10.1097/ICO.0000000000000185] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 3.6] [Reference Citation Analysis]
10 Moussa S, Reitsamer H, Ruckhofer J, Grabner G. The Ocular Surface and How It Can Influence the Outcomes of Keratoprosthesis. Curr Ophthalmol Rep 2016;4:220-5. [PMID: 28936371 DOI: 10.1007/s40135-016-0116-x] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Malandrini A, Balestrazzi A, Canovetti A, Rossi F, Cortesini L, Lenzetti C, Pini R, Menabuoni L. Improving Boston type 1 keratoprosthesis procedure: one-touch femtosecond-assisted preparation and centration of donor carrier tissue. Eur J Ophthalmol 2014;24:191-5. [PMID: 24338585 DOI: 10.5301/ejo.5000387] [Reference Citation Analysis]
12 Al Arfaj K. Boston keratoprosthesis - Clinical outcomes with wider geographic use and expanding indications - A systematic review. Saudi J Ophthalmol 2015;29:212-21. [PMID: 26155082 DOI: 10.1016/j.sjopt.2015.02.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
13 Chen M, Ng SM, Akpek EK, Ahmad S. Artificial corneas versus donor corneas for repeat corneal transplants. Cochrane Database Syst Rev 2020;5:CD009561. [PMID: 32408386 DOI: 10.1002/14651858.CD009561.pub3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Pelletier JS, Barone SB, Capriotii JA. Keratoprosthesis prophylaxis: is it time for a paradigm shift? Clin Ophthalmol 2018;12:1785-8. [PMID: 30254417 DOI: 10.2147/OPTH.S178622] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Nonpassopon M, Niparugs M, Cortina MS. Boston Type 1 Keratoprosthesis: Updated Perspectives. Clin Ophthalmol 2020;14:1189-200. [PMID: 32425503 DOI: 10.2147/OPTH.S219270] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
16 Malhotra C, Dhingra D, Jain AK. Keratoprosthesis optic and carrier corneal graft "noncontact" as a cause of sterile stromal necrosis in a case of Auro KPro implantation. Indian J Ophthalmol 2019;67:685-6. [PMID: 31007242 DOI: 10.4103/ijo.IJO_1713_18] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Lee SM, Kim MK, Shin MS, Wee WR. Matrix metalloproteinase-9 expression in the Seoul-type keratoprosthesis implanted corneas with concurrent cultivated autologous oral mucosal epithelial cell transplantation. Graefes Arch Clin Exp Ophthalmol 2013;251:619-22. [PMID: 22252113 DOI: 10.1007/s00417-011-1923-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Shihadeh WA, Mohidat HM. Outcomes of the Boston keratoprosthesis in jordan. Middle East Afr J Ophthalmol 2012;19:97-100. [PMID: 22346122 DOI: 10.4103/0974-9233.92123] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
19 Salvador-Culla B, Kolovou PE. Keratoprosthesis: A Review of Recent Advances in the Field. J Funct Biomater 2016;7:E13. [PMID: 27213461 DOI: 10.3390/jfb7020013] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
20 Akpek EK, Alkharashi M, Hwang FS, Ng SM, Lindsley K. Artificial corneas versus donor corneas for repeat corneal transplants. Cochrane Database Syst Rev 2014;:CD009561. [PMID: 25372407 DOI: 10.1002/14651858.CD009561.pub2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
21 Behlau I, Mukherjee K, Todani A, Tisdale AS, Cade F, Wang L, Leonard EM, Zakka FR, Gilmore MS, Jakobiec FA, Dohlman CH, Klibanov AM. Biocompatibility and biofilm inhibition of N,N-hexyl,methyl-polyethylenimine bonded to Boston Keratoprosthesis materials. Biomaterials 2011;32:8783-96. [PMID: 21903257 DOI: 10.1016/j.biomaterials.2011.08.010] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
22 Fernandez AG, Radcliffe NM, Sippel KC, Rosenblatt MI, Sood P, Starr CE, Ciralsky JB, D'Amico DJ, Kiss S. Boston type I keratoprosthesis-donor cornea interface evaluated by high-definition spectral-domain anterior segment optical coherence tomography. Clin Ophthalmol 2012;6:1355-9. [PMID: 22969280 DOI: 10.2147/OPTH.S34787] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
23 Patel AP, Wu EI, Ritterband DC, Seedor JA. Boston type 1 keratoprosthesis: the New York Eye and Ear experience. Eye (Lond) 2012;26:418-25. [PMID: 22173079 DOI: 10.1038/eye.2011.325] [Cited by in Crossref: 64] [Cited by in F6Publishing: 45] [Article Influence: 5.8] [Reference Citation Analysis]